Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Teresa Bilotta

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|November 7, 2022
Managing the TME to improve the efficacy of cancer therapyMaria Teresa Bilotta, Antonella Antignani, David J Fitzgerald
Frontiers in Immunology|November 23, 2020
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and CancerMaria Teresa Bilotta, Sara Petillo, Angela Santoni, et al.
Methods in Cell Biology|November 8, 2024
Myeloid-derived suppressor cells: Identification and functionPaola Vacca, Maria Teresa Bilotta, Lorenzo Moretta, et al.
Cancers|July 15, 2026
Myeloid-Derived Suppressor Cells in Cancer: Metabolic Reprogramming, Immune Crosstalk, and Therapeutic TargetingAndrea Sabatini, Maria Rita Assenza, Maria Teresa Bilotta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 2, 2022
Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activityEric Chun Hei Ho, Rong Qiu, Ellis Miller, et al.
Biomolecules|September 22, 2020
Targeting Receptors on Cancer Cells with Protein ToxinsAntonella Antignani, Eric Chun Hei Ho, Maria Teresa Bilotta, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 16, 2023
Birinapant selectively enhances immunotoxin-mediated killing of cancer cells conditional on the IAP protein levels within target cellsAntonella Antignani, Maria Teresa Bilotta, Jacob S Roth, et al.
Experimental Eye Research|May 24, 2026
Experimental Protocol for Ocular Surface Immune Cell Isolation and Functional Analysis Using Schirmer Test StripsMaria Teresa Bilotta, Andrea Sabatini, Maria Rita Assenza, et al.
Allergy|March 12, 2025
Immunophenotyping in Vernal Keratoconjunctivitis: Schirmer Test for Therapy Response PredictionMaria Teresa Bilotta, Paola Vacca, Mariacristina Esposito, et al.
Cell Death & Disease|April 13, 2019
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitorsMaria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|November 7, 2022
Managing the TME to improve the efficacy of cancer therapyMaria Teresa Bilotta, Antonella Antignani, David J Fitzgerald
Frontiers in Immunology|November 23, 2020
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and CancerMaria Teresa Bilotta, Sara Petillo, Angela Santoni, et al.
Methods in Cell Biology|November 8, 2024
Myeloid-derived suppressor cells: Identification and functionPaola Vacca, Maria Teresa Bilotta, Lorenzo Moretta, et al.
Cancers|July 15, 2026
Myeloid-Derived Suppressor Cells in Cancer: Metabolic Reprogramming, Immune Crosstalk, and Therapeutic TargetingAndrea Sabatini, Maria Rita Assenza, Maria Teresa Bilotta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 2, 2022
Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activityEric Chun Hei Ho, Rong Qiu, Ellis Miller, et al.
Biomolecules|September 22, 2020
Targeting Receptors on Cancer Cells with Protein ToxinsAntonella Antignani, Eric Chun Hei Ho, Maria Teresa Bilotta, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 16, 2023
Birinapant selectively enhances immunotoxin-mediated killing of cancer cells conditional on the IAP protein levels within target cellsAntonella Antignani, Maria Teresa Bilotta, Jacob S Roth, et al.
Experimental Eye Research|May 24, 2026
Experimental Protocol for Ocular Surface Immune Cell Isolation and Functional Analysis Using Schirmer Test StripsMaria Teresa Bilotta, Andrea Sabatini, Maria Rita Assenza, et al.
Allergy|March 12, 2025
Immunophenotyping in Vernal Keratoconjunctivitis: Schirmer Test for Therapy Response PredictionMaria Teresa Bilotta, Paola Vacca, Mariacristina Esposito, et al.
Cell Death & Disease|April 13, 2019
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitorsMaria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda, et al.
Pageof 2